Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hari Cheryl Sachs

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pediatrics|August 28, 2013
The transfer of drugs and therapeutics into human breast milk: an update on selected topicsHari Cheryl Sachs,
Clinical Therapeutics|October 26, 2006
Cardiovascular support in preterm infantsJacquelyn R Evans, Billie Lou Short, Krisa Van Meurs, et al.
Journal of Long-Term Effects of Medical Implants|November 1, 2006
Breast implant surveillance reports to the U.S. Food and Drug Administration: maternal-child health problemsS Lori Brown, Joan Ferlo Todd, Judith U Cope, et al.
Pediatrics|June 17, 2006
The newborn drug development initiativeGeorge P Giacoia, Debra L Birenbaum, Hari Cheryl Sachs, et al.
Pediatric Clinics of North America|November 28, 2017
Development of Drug Therapies for Newborns and Children: The Scientific and Regulatory ImperativesYeruk Lily Mulugeta, Anne Zajicek, Jeff Barrett, et al.
Pediatrics|January 2, 2003
Community norms on toy gunsTina L Cheng, Ruth A Brenner, Joseph L Wright, et al.
Pediatrics|July 3, 2004
Children's violent television viewing: are parents monitoring?Tina L Cheng, Ruth A Brenner, Joseph L Wright, et al.
The AAPS Journal|January 22, 2013
Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infantsJane P F Bai, Jeffrey S Barrett, Gibert J Burckart, et al.
Clinical Pharmacology and Therapeutics|February 8, 2020
Exposure-Response Assessment in Pediatric Drug Development Studies Submitted to the US Food and Drug AdministrationYifei Zhang, Yaning Wang, Mona Khurana, et al.
Frontiers in Pediatrics|November 1, 2021
Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model DevelopmentSherry Zhao, Mary Gockenbach, Manuela Grimstein, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pediatrics|August 28, 2013
The transfer of drugs and therapeutics into human breast milk: an update on selected topicsHari Cheryl Sachs,
Clinical Therapeutics|October 26, 2006
Cardiovascular support in preterm infantsJacquelyn R Evans, Billie Lou Short, Krisa Van Meurs, et al.
Journal of Long-Term Effects of Medical Implants|November 1, 2006
Breast implant surveillance reports to the U.S. Food and Drug Administration: maternal-child health problemsS Lori Brown, Joan Ferlo Todd, Judith U Cope, et al.
Pediatrics|June 17, 2006
The newborn drug development initiativeGeorge P Giacoia, Debra L Birenbaum, Hari Cheryl Sachs, et al.
Pediatric Clinics of North America|November 28, 2017
Development of Drug Therapies for Newborns and Children: The Scientific and Regulatory ImperativesYeruk Lily Mulugeta, Anne Zajicek, Jeff Barrett, et al.
Pediatrics|January 2, 2003
Community norms on toy gunsTina L Cheng, Ruth A Brenner, Joseph L Wright, et al.
Pediatrics|July 3, 2004
Children's violent television viewing: are parents monitoring?Tina L Cheng, Ruth A Brenner, Joseph L Wright, et al.
The AAPS Journal|January 22, 2013
Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infantsJane P F Bai, Jeffrey S Barrett, Gibert J Burckart, et al.
Clinical Pharmacology and Therapeutics|February 8, 2020
Exposure-Response Assessment in Pediatric Drug Development Studies Submitted to the US Food and Drug AdministrationYifei Zhang, Yaning Wang, Mona Khurana, et al.
Frontiers in Pediatrics|November 1, 2021
Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model DevelopmentSherry Zhao, Mary Gockenbach, Manuela Grimstein, et al.
Pageof 2